| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10x Genomics, Inc. (TXG) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 71 sells. TXG is classified in the Health Care Technology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.07M | $30.90M | - | |
| Other | 432.6K | $12.48M | - | |
| Dir | 368.4K | $10.63M | - | |
| CFO | 297.4K | $8.58M | - | |
| Dir | 85.9K | $2.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2021 | Saxonov Serge80 | Chief Executive Officer | Sale+OE | 15,000 | $157.04 | $2,355,568.51 | -0.3% | +12.8% | -63.6% | |
| Mar 8, 2021 | McAnear Justin J.84 | Chief Financial Officer | Sale+OE | 10,000 | $147.30 | $1,472,954.46 | -3.3% | - | - | |
| Mar 1, 2021 | Stuelpnagel John R89 | Director | Sell | 7,500 | $183.18 | $1,373,887.25 | -0.2% | - | - | |
| Feb 16, 2021 | Stuelpnagel John R89 | Director | Sell | 7,500 | $193.00 | $1,447,515.54 | -0.2% | - | - | |
| Feb 1, 2021 | Stuelpnagel John R89 | Director | Sell | 7,500 | $176.05 | $1,320,379.67 | -0.3% | - | - | |
| Feb 1, 2021 | Saxonov Serge80 | Chief Executive Officer | Sale+OE | 10,000 | $176.00 | $1,760,042.71 | -0.2% | - | - | |
| Feb 1, 2021 | McAnear Justin J.84 | Chief Financial Officer | Sale+OE | 10,000 | $176.05 | $1,760,478.91 | -7.7% | - | - | |
| Feb 1, 2021 | Crutchfield Bradford87 | Chief Commercial Officer | Sale+OE | 17,000 | $175.99 | $2,991,765.44 | -6.6% | - | - | |
| Feb 1, 2021 | Hindson Benjamin J.82 | See Remarks | Sell | 33,750 | $175.98 | $5,939,455.88 | -10.3% | - | - | |
| Jan 19, 2021 | Stuelpnagel John R89 | Director | Sell | 7,500 | $178.76 | $1,340,699.22 | -0.2% | - | - |